On Dec. 17, the Illinois Department of Public Health reaffirmed its recommendation for a universal hepatitis B vaccination at birth.

The US Centers for Disease Control and Prevention officially abandoned universal hepatitis B vaccination for newborns on ...

IDPH reaffirms universal hepatitis B vaccine at birth to protect Illinois newborns from liver disease, following IL-IAC ...

AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company developing targeted oligonucleotide therapies for functional cure of chronic ...

Hepatitis B vaccine at birth is safe, effective, and gives long lasting protection from an infection that can have ...

The vaccine, which “virtually eliminated” the disease in children, will no longer be given at birth unless parents request it ...

On Dec. 5, a federal vaccine advisory panel voted to change the long-standing recommendation that all newborns receive a dose ...

Recently, A federal vaccine advisory committee voted to end a longstanding recommendation that all U.S. babies get the ...

The Arkansas Department of Health is examining its "updated immunization policy," but does not expect any change to school ...

Most Democratic-led states will continue to recommend the hepatitis B vaccine at birth, despite a CDC advisory panel’s vote ...

The Illinois Department of Public Health reaffirmed its recommendation that newborn infants receive a hepatitis B vaccine ...

First CTA authorization marks nChroma's transition to a clinical-stage company; first patient dosing in Phase 1/2 trial planned for early 2026 Preclinical studies demonstrated CRMA-1001 delivers ...